Epithelial to Mesenchymal Transition: Key Regulator of Pancreatic Ductal Adenocarcinoma Progression and Chemoresistance

Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest malignancies, characterized by aggressive biological behavior and a lack of response to currently available chemotherapy. Emerging evidence has identified epithelial to mesenchymal transition (EMT) as a key driver of PDAC progression an...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Kostas Palamaris, Evangelos Felekouras, Stratigoula Sakellariou
Format:	article
Langue:	EN
Publié:	MDPI AG 2021
Sujets:	pancreatic ductal adenocarcinoma epithelial to mesenchymal transition cancer stem cells intratumor heterogeneity tumor microenvironment chemoresistance Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Accès en ligne:	https://doaj.org/article/7e5ad0ffe3884d85ae1ff2f7a8f1c09d
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Soyez le premier à ajouter un commentaire!

Epithelial to Mesenchymal Transition: Key Regulator of Pancreatic Ductal Adenocarcinoma Progression and Chemoresistance

Documents similaires